Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
58.73B | 58.57B | 57.74B | 67.13B | 69.46B | 71.18B | Gross Profit |
19.26B | 19.39B | 18.89B | 19.44B | 19.89B | 18.49B | EBIT |
2.39B | 2.28B | 2.06B | 2.15B | 2.30B | 1.90B | EBITDA |
3.63B | 3.52B | 3.40B | 3.41B | 3.31B | 3.76B | Net Income Common Stockholders |
1.48B | 1.19B | 1.07B | 1.06B | 798.21M | 1.30B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
911.00M | 708.29M | 822.02M | 553.95M | 1.04B | 808.59M | Total Assets |
43.14B | 42.75B | 43.77B | 43.26B | 45.75B | 47.68B | Total Debt |
3.97B | 6.29B | 8.84B | 10.20B | 13.12B | 15.62B | Net Debt |
3.06B | 5.59B | 8.02B | 9.65B | 12.08B | 14.82B | Total Liabilities |
17.22B | 17.90B | 20.06B | 20.60B | 24.07B | 26.73B | Stockholders Equity |
25.89B | 24.81B | 23.68B | 22.63B | 21.63B | 20.91B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.67B | 2.73B | 2.32B | 1.90B | 1.61B | Operating Cash Flow |
0.00 | 3.72B | 3.64B | 4.16B | 3.37B | 3.22B | Investing Cash Flow |
0.00 | -1.13B | -885.00M | -1.44B | -508.82M | -1.38B | Financing Cash Flow |
0.00 | -2.70B | -2.49B | -3.21B | -2.62B | -1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥10.47B | 7.00 | 2.38% | 15.66% | 2.87% | ||
77 Outperform | ¥9.13B | 9.28 | 4.31% | 2.42% | 154.96% | ||
76 Outperform | ¥11.63B | 11.08 | 1.55% | 6.01% | -21.51% | ||
73 Outperform | ¥10.96B | 6.93 | 1.47% | 0.19% | 32.51% | ||
65 Neutral | $8.88B | 15.03 | 4.75% | 203.74% | 3.58% | -2.49% | |
55 Neutral | ¥12.30B | ― | 2.39% | 0.65% | -679.30% | ||
41 Neutral | ¥10.09B | ― | ― | -5.60% | -23.60% |